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Abstract
This paper investigates the institutional change process underpinning the emergence of rege-
nerative medicine and related medical innovation in Tampere, Finland. The main aim is to in-
vestigate how institutional entrepreneurship has influenced the course of events and what roles 
the key actors have played. The empirical analysis shows that institutional entrepreneurship is 
a multi-scalar and multi-actor force in time and, that no single actor has led the process in a 
conventional sense but there have been several actors who have played leading roles in different 
phases of the process. This paper shows that institutional entrepreneurship is a strategic relay 
of power and knowledge in time. This paper is based on the analysis of secondary data and 28 
interviews of key actors. 
IntroductIon
This paper provides the answer to the question: what do people do to influence the course 
of events in their efforts to create local conditions for science-based innovation? More 
specifically, the question is about how world-class regenerative medicine came about in 
Tampere, Finland
The point of departure here is that we need to complement the relatively established focus 
of regional innovation studies from investigating mainly organisations (actors as components 
of systems), rules of the game (institutions) and interaction patterns (networks) (see e.g. 
Braczyk, Cooke & Heidenreich, 1998; Cooke, Uranga & Etxebarria, 1997; Asheim & Isaksen 
2002) and/or innovation activities, knowledge flows and knowledge bases (see e.g. Asheim & 
Gertler 2005; Asheim et al, 2006) towards the integration of better understanding of what 
people actually do when they aim to boost science-based innovation. This is not to argue 
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that the traditional focusing devices would be irrelevant or would not produce good results. 
On the contrary, there is still a lot to do so that we can better understand the dynamics of 
various innovation systems in differing contexts. The argument here is that studies focusing 
on regional innovation systems have been relatively blind to the roles various individuals play 
in the innovation world (Uyarra, 2010) and that by adopting more micro-level analytical 
frameworks we might learn more about interactive innovation processes and, most importantly, 
we might learn to understand better how various actors behave in these contexts; how they 
interact, relate and evolve with wider institutional constellations in their efforts to create 
something new. 
From this premise, the paper investigates the institutional and organisational change 
underpinning the emergence and intentional creation of regenerative medicine in Tampere, 
Finland. A deeper understanding of innovation in healthcare remains a major challenge for 
research in the social sciences, as well as being a major concern for human well-being. In 
healthcare, there is a major need for innovation and renewal; a need to provide services for 
more people and a need to increase the quality of health services without any significant extra 
finance. In this wider context, this paper focuses on regenerative medicine that has progressed 
rapidly with tremendous hype as well as hope. The most positive commentators argue that 
regenerative medicine will become one of the three main forms of medical treatment alongside 
medication and surgery (Valtakari, Rajahonka & Tikkanen, 2007). The most negative 
commentators argue that regenerative medicine is full of empty promises and more hype 
than actual treatments (for more see: Brown 2003; Nadig 2009). 
This paper shows how a new concentration of regenerative medicine with strong local 
and global connections was established in Tampere. Furthermore it shows what kind of 
institutional path, relay of actions and decisions led to the radical new treatments that were 
carried out for the first time, anywhere in the world. The main aims of this paper are: 
to identify what drives the emergence of a new concentration of innovation in the field of a) 
regenerative medicine and stem cell research; 
to identify what are the main institutions facilitating and/or hampering this process; and b) 
to identify who are the main agents of change in the selected context, and how they c) 
influence the course of events and attack those very same institutions that frame their own 
actions.
To answer the questions set out here we follow Kay (2006: p.39) who says that ‘to understand 
how institutions evolve, it may be more fruitful to aim for a more fine-grained analysis that 
seeks to identify what aspects of a specific institutional configuration are (or are not) negotiable 
and under what conditions’. Hence, the aim is also to show how it is possible to ‘account 
for and understand the layering of institutions and their multi-scalar interaction’ (Gertler, 
2010: p.7) from a processual and human agency point of view. We endorse Gertler’s view that 
too much micro-level analysis on regional development and innovation systems would not 
provide much insight on institutional change. As Gertler (2010: p.4) argues, there often is ‘too 
much actor, not enough structure’. By adopting institutional entrepreneurship and leadership 
as key focusing devices it is possible to find a balance between structure and actor.
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regIonal InnovatIon systems and the challenge to mould 
InstItutIons
Innovation systems and institutions
We limit ourselves from discussing the concept of regional innovation systems in depth and 
simply refer to the extensive body of literature that provides students of innovation and regional 
development with an abundant body of conceptual tools and empirical insights to work with. 
This dynamic body of work shows how industries and firms are embedded in national, sectorial 
and/or regional systems of innovation (Lundvall 1992; Cooke, 2004; Malerba 2002) and how 
regional innovation systems are constructed on knowledge-creating and knowledge-utilising 
sub-systems (Autio, 1998). The various approaches on innovation systems stress, according to a 
narrow definition, ‘interacting private and public firms, universities, and government agencies 
aiming at the production of science and technology’ (Niosi et al, 1993), and ‘networks of 
institutions that in interaction initiate, import, modify, and diffuse new technologies’ (Freeman, 
1987). Additionally, according to a broader view, innovation system studies focus broadly on 
organisations and institutions affecting and supporting learning and innovation, in practice, 
embracing potentially the entire society (Asheim & Gertler, 2005: p. 300.) 
To summarise, the system of innovation encompasses the determinants of innovation 
processes, i.e. all important economic, social, political, organisational, and other institutional 
factors that influence the development, diffusion, and use of new knowledge (Edquist, 2008: 
p.5) and have an influence on individuals’, firms’ and organisations’ learning capacity and 
hence on their ability to innovate (Lundvall, 1992; Lundvall et al, 2002). All this is supposed 
to produce ‘new creations of economic significance’, i.e. innovations that are widely accepted 
as primary sources of renewal in a global and capitalistic economy (e.g. Edquist, 2005). 
Consequently, to truly reinvent itself and boost innovation a region needs to be able to: 
identify institutions that are locking it into the past or slowing its transformation down; a) 
abolish and/or renew these institutions; and b) 
create new institutions which support the emergence of a new development path. c) 
Edquist (2008: p.15) raises the creation, abolishing, and changing of institutions as among the 
most important activities in maintaining (and also increasing) the dynamism of innovation 
systems. 
On a general level, institutions that need to be moulded for innovation are ‘the kinds 
of structures that matter most in the social realm’ (Hodgson, 2006: p.2) and ‘a relatively 
enduring collections of rules and organized practices, embedded in structures of meaning 
and resources that are relatively invariant in the face of turnover of individuals and relatively 
resilient to the idiosyncratic preferences and expectations of individuals and changing external 
circumstances’ (March and Olsen 2005: p.4). Scott (2001) maintains that institutions are 
composed of regulative (rule setting, monitoring, rewarding and sanctioning activities), 
normative (values and norms that lay emphasis on rules that introduce a prescriptive, 
evaluative and obligatory dimension into social life) and cultural-cognitive elements (external 
frameworks shaping internal interpretation processes). More specifically, institutions framing 
and shaping innovation systems include intellectual property rights laws; various standards; 
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laws; environment, safety and ethical regulations; organisation-specific rules; industry 
specialisation and structure; governance structure; financial system; structure of the research 
and development (R&D); R&D investment routines; training and competence building 
systems as well as operational cultural factors (see e.g. Edquist 2005; 2008; Autio, 1998; 
Braczyk, Cooke & Heidenreich, 1998; Howells, 1999). 
The nature of institutions and institutional change
When studying institutional change there is a danger to fall into a ‘radical change trap’ and 
focus mainly on those changes that are easy to detect and observe and, to see change as a 
discontinuous period between periods of stability and continuity. It might be more fruitful 
to approach change as a normal state of affairs instead of an anomaly (Pettigrew, 1992). This 
notion highlights the need to be more sensitive to gradual transformations instead of abrupt 
changes only. Incremental changes are not only reactive and adaptive for the protection of 
institutional continuity. Due to accumulation over longer periods of time subtle, seemingly 
minor changes can lead to considerable discontinuity that may surface beneath the apparent 
stability. Indeed, ‘creeping change’ (gradual transformation), suggests that there are no 
optimum states but a constant search is a core in institutional change processes (Streeck and 
Thelen, 2005). All this suggests that when studying institutional entrepreneurship we need 
to be sensitive to continuity and discontinuity as well as incremental and abrupt changes and 
their combinations. 
The call for conscious efforts to mould institutions signifies that there ought to be actors 
who work to change those habits, conventions, and routines as well as constitutive rules and 
practices that prescribe what is appropriate behaviour for specific actors in specific situations 
(Morgan, 1997; March and Olsen, 2005). When considering this, and all those institutions 
that govern innovation systems, there is no doubt that ‘changing institutions’ is not a joyride. 
To create and change institutions and hence innovation systems requires meddling with 
complex reciprocal relationships between actors as well as untying the old ones.
Institutions are more often than not treated as constraining forces that regularise and select 
behaviour rather than sources of change and innovation. Institutions are normally seen as 
sources of stability and order (Scott, 2001: p.181), but this is a more theoretical than empirical 
understanding (Harty, 2005). First of all, it is believed here that institutions also have an 
enabling role (Hage, 2006; Hollingsworth, 2000; Scott, 2007) and second, that institutions 
ought to be interpreted both as an object of change itself and as a constraining, as well as an 
enabling and incentivising, structure for change (Soskice, 1999: p.102). These two beliefs 
reflect two other assumptions that guide this study: 
there is a need for a deeper understanding of transformation processes of innovation a) 
systems at an institutional level (Lundvall et al, 2002: p. 225); and 
this can be achieved by studying those actors who work to change institutions b) 
(institutional entrepreneurs). 
The latter part reflects the belief that there are indeed actors who work to change institutions 
governing also their own behaviour. Even though institutions select behaviour (March and 
Olsen 1996: pp. 251-255) actors also have some freedom to operate (Jessop 2004: p. 40). 
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Therefore, institutions can be studied as outcomes of complex social processes and as such 
they are seen here as products of human agency (DiMaggio and Powell, 1991). 
InstItutIonal entrepreneurshIp as a key analytIcal focusIng 
devIce
From components of systems to purposive actors
In the field of regional innovation studies it is habitual to see actors more as components of 
the system rather than as purposive agents (Uyarra & Flanagan, 2010: p. 683). As they argue 
further, innovation studies tend also to focus more on the presence or absence of predefined 
actors and institutions than on their roles, relationships, and performance not to mention the 
lack of discussion about the emergence, evolution, restructuring, or even disappearance of actors 
and institutions. Consequently, one of the central challenges in regional innovation system 
studies is to show how and why embedded actors become purposive, motivated and enabled 
to promote institutional change for innovation, and to that end we also need to discover how 
various individuals and groups exercise power and aim to influence (Sotarauta & Pulkkinen, 
2011). 
Institutional entrepreneurs are the core of endeavours to shape the institutional base for 
innovation. Institutional entrepreneurship provides an analytical framework to study what 
various agents do in cooperation or competition with each other to change institutions; 
how they interact, relate and evolve with wider institutional constellations. Especially 
important for this line of study is the notion that micro-agent change leads to macro-system 
evolution, i.e. before change at a macro-level can be seen, it takes place at many micro-levels 
simultaneously and, this allows us to find fresh approaches to understand institutional change 
from the bottom-up. These kinds of micro-approaches are usually more actor-centred than 
macro-approaches and more often than not they concentrate on entrepreneurial behaviour of 
innovative firms that give rise to knowledge creation and diffusion inside firms and within a 
region (Uyarra, 2010: pp. 122-123). However, the entrepreneurial behaviour of institutional 
entrepreneurs who are engaged in various efforts to change institutions framing innovation 
systems is more or less a neglected issue. Institutional entrepreneurship highlights agency, 
interests, legitimacy, strategy and power (Levy and Scully, 2007) in the analysis of regional 
innovation systems while the more conventional approaches highlight actors, institutions, 
interaction patterns and knowledge bases.  
Indeed, it seems that ‘one of the most common pitfalls of an institutional approach is 
the constant temptation to want to “read off ” individual behaviour from national (or local) 
institutional structures’ (Gertler, 2010: p. 5.) Consequently, this paper proposes that there is a 
need to address contemporary challenges in the field of (regional) innovation studies by analysing 
the encounters of institutional entrepreneurs and institutions, i.e., the ways in which actors aim 
to change the very institutions that govern their own activities. The proposition, however, does 
not involve predestined causality between actions of a single actor and/or groups of actors and 
institutional change. At best, institutional entrepreneurship studies are a form of process-oriented 
inquiry where the role of actors is fleshed out by analysing the change processes. 
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How do we know when we see an institutional entrepreneur?
Institutional entrepreneurship challenges some of the prevailing notions of institutional 
change as well as regional innovation systems. First, institutional entrepreneurship challenges 
the relatively shared notion that institutions select behaviour (March and Olsen, 1996: 
pp. 251-255) by arguing that in the final analysis actors actually have some freedom to operate 
(Jessop, 2004: p.40) and, that there are indeed actors who entrepreneurially work to change 
institutions (Battilana, 2006). 
Institutional entrepreneurship refers to the ‘activities of actors who have an interest in 
particular institutional arrangements and who leverage resources to create new institutions 
or to transform existing ones’ (Garud, Hardy & Maguire, 2007: p.957) and, as a concept, 
it is mainly associated with DiMaggio (1988: p.14) who maintains that ‘new institutions 
arise when organized actors with sufficient resources see in them an opportunity to realize 
interests that they value highly’. Institutional entrepreneurs can be organisations or groups of 
organisations or individuals or groups of individuals who act as change agents (Battilana, Leca 
& Boxenbaum, 2009) and hence, they are actors who initiate divergent changes and actively 
participate in the implementation of these changes. Therefore, only actors who initiate changes 
that break with the institutionalised template can be regarded as institutional entrepreneurs 
(Battilana, Leca & Boxenbaum, 2009: p.67). The endeavours to shape the institutional 
base for innovation systems reflect the many strategies adopted by relevant groups of actors 
aiming to break out from the past path and create new ones. Of course, it goes without 
saying that the freedom of institutional entrepreneurs to forge change is often limited in a 
world dominated by rigid structures, politics, major economic players and formal policies. 
Institutional entrepreneurship is a form of ‘embedded agency’. These actors are constrained 
by the very same institutions they aim to mould (see more, concerning embedded agency, in 
Battilana, 2006; Leca and Naccache, 2006; Seo and Creed, 2002).
Consequently, institutional entrepreneurship needs to be studied with three perspectives 
in mind (see Sotarauta & Pulkkinen, 2011): 
the a) process perspective that informs a study on the dynamism of regional innovation 
systems and secures a temporally conscious approach (regional innovation journeys are 
discussed in more detail below); 
the b) network perspective that informs about the social relationships of the actors in and 
beyond a regional innovation system; and 
the c) governance perspective that informs about the wider systemic issues framing 
and moulding both the actual systems and journeys as well as forms of institutional 
entrepreneurship. 
A core belief underlying our approach is the importance of understanding interactions between 
actors and their institutional settings. It is more or less impossible to understand institutional 
entrepreneurship without understanding how actors shape institutions they are embedded 
into and how institutions shape their actions. This calls for relational, contextual and systemic 
understanding. The proposition here is not to take regional innovation studies towards leader-
centric approaches. On the contrary, to study institutional entrepreneurship is to study 
forces changing the institutions governing innovation and hence, the proposition is to take 
innovation system studies towards a micro-level/processual approach by using institutional 
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entrepreneurs as analytical focusing devices to study regional innovation journeys, i.e. all 
those processes that for their part transform ordinary regions into innovation-driven ones 
(Benneworth, 2007: p.4). Our process and network-oriented approach locates institutional 
entrepreneurship not in the attributes of individuals but in the relationships connecting actors 
in an innovation journey.
Leadership capacity and institutional entrepreneurship
It goes without saying that conscious efforts to change the socio-economic-political setting 
for innovation requires changes not only in formal institutions but also in delicate inter-
personal relationships between autonomous agents. This poses a great challenge not only 
for innovation policy and governance system but also for the leadership capacity of people 
engaged in boosting innovation systems in one way or another. It is also a challenge because 
moulding institutions and leading complex networks is a dynamic process while the literature 
deals mainly with static structural elements of regional innovation systems with less emphasis 
on temporal issues. In dynamic regional innovation systems institutional entrepreneurs need 
strong leadership capacity.
 As Yukl (2002: p.2) concludes, most definitions of leadership involve a process whereby 
‘intentional influence is exerted by one person over other people to guide, structure, and 
facilitate activities and relationships in a group or organization’. Leadership scholars base their 
definitions of leadership on the nature of influence and the role of individuals who are defined 
as leaders. They often define leadership in terms of a group process, traits, behaviours, or as 
an instrument of goal achievement (Bass & Bass 2008 for a detailed review). In line with Yukl 
(2002), we define leadership as a process of influencing and teaching others to understand 
why and how certain activities and goals need to be accomplished. As such, it constitutes a 
process of facilitating individual and collective efforts to learn and accomplish shared goals. 
Leadership definitions include social influence and one of the leaders’ key roles is to set a 
purpose or vision of change (e.g. Bass, 2008). 
The much flagged ‘stars of the knowledge era’ (Silicon Valley, Cambridge, Boston, etc.) have 
provided the rest of the world with ways of how to construct competitive advantage, but as 
Benneworth (2007: p.12) maintains, ‘ordinary regions typically face the challenge that they have 
an outdated understanding of their economy, and need to develop a new vision and understanding 
of how they can survive in the knowledge economy’. Indeed, as they push their view forward, ‘the 
issue then becomes how regions can change their collective developmental model to something, 
which is more attuned to how their existing assets can produce global competitive advantage’ 
(Benneworth 2007). In this kind of context, institutional entrepreneurship is fairly often seen 
simplistically as top-down command and control rather than a subtle and multifaceted process 
of pooling many kinds of capabilities, resources and power in time. By definition, it is more or 
less impossible to ‘control’ multi-actor efforts to promote regional innovation. Conscious efforts 
to boost regional innovation systems are constrained by a sense of what is possible and what is 
not as well as by legacies and forebodings. Indeed, the nature of regional innovation systems as 
an uncertain and ambiguous set of sub-processes is exactly why we highlight the need to study 
long-term processes from an institutional entrepreneurship perspective. 
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In spite of not discussing explicitly regional innovation systems Gibney, Copeland, & 
Murie (2009: p. 5) provide additional clues for the definition of leadership in this context 
by acknowledging that economic development increasingly calls for the integration of many 
earlier separate spheres of life, most notably economic, political and social life. As they also say, 
collective action requires a form of leadership that generates, renews and sustains the collective 
learning cycle over extended periods of time. As argued above, this kind of leadership is not 
time-limited but time-extensive. To make the challenge even more formidable, institutional 
entrepreneurs in innovation journeys need to look beyond the short-termism of performance 
goals and the mandatory (Gibney, Copeland, & Murie, 2009: p.9), i.e. everything under 
normal administrative radar. 
Power and knowledge 
If institutional entrepreneurship and leadership are not specialised roles but diffused processes 
in which different actors exercise different influences, the first question obviously is, who 
are they, and the second, how do they interact in time? The answer should not entail any 
predefined assumption based on formal positions but a careful process analysis on who have 
influenced and how and what kind of power base they have and how they exercise power in 
relation to other forms of power.  Being aware of the fact that the concept of power is among 
the key concepts in social sciences, with its several dimensions and definitions and that there 
is a rich array of ways in which to conceptualise and study it, we define it here simply as ‘the 
capacity of some persons to produce intended and foreseen effects on others’ (Wrong, 1997: 
p. 2.). Hence, in power the question is about the actor’s control of the behaviour of other 
actors. Of course, we also need to take into account the power of social systems and structures, 
i.e. the fact that institutions are actually both subjects and objects of change and/or stability. 
As Foucalt (1980) famously claims, belief systems gain power when groups of people accept 
a belief system and take it for granted. Belief systems define the arena for many actors, affect 
institutional design, and are often institutions in themselves (Foucault, 1980) and therefore, 
we also need to acknowledge networked relationships of power and see them as the relational 
effect of social interaction (Allen, 2003: pp. 2, 60-64). 
Drawing on his empirical study on the power and influence tactics of Finnish regional 
development officers Sotarauta (2009: pp. 901-902) concludes that network power and 
interpretive power are the most important sources of influence in networked situations. The 
study shows that those actors having interpretive power can create a new vocabulary and 
a new way of seeing a region and its core activities and that actors having network power 
convene actors for dialogue and remove obstacles between various actors. Those actors having 
network power can utilise the resources and competencies of their partners, bring actors 
together, remove obstacles hindering communication, set the agenda, resolve conflict, enable 
information flow, build trust, link different matters to each other, orient people to their places 
and roles, inspire, excite, and so forth. Interpretive and network power are fairly invisible by 
nature. They do not refer to efforts to seek consensus but efforts to create common ground 
for shared thinking and joint efforts to transform the institutions for future. In the exercise 
of network power the significance of informal and personal contact networks as resources of 
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new information and credibility becomes important (Sotarauta, 2009). Power to frame issues 
discussed, to lead sense-making processes and hence to influence what issues are on the agenda 
and what are not, and consequently also who are involved in the interactive communication 
loop brings a significant amount of interpretive power to an actor who can actually do all 
this. 
Even though interpretive and network power were highlighted in the study on regional 
development officers, we should not neglect the importance of institutional power and 
resource power. Institutional power refers to the power to act and decide and the power to 
create institutions and formulate official strategies, i.e. direct power exercised by official actors. 
Here, resource power is simply seen to refer to power to direct resources (see for more in detail 
Sotarauta, 2009: p. 902). In this study, we assume that the power exercised by institutional 
entrepreneurs is relational in nature and, that it is exercised either alone or in concert with 
other forms of power that in tandem draw as much from dialogue and interaction skills as 
on the expertise in substantial matters and legitimate power (power of an individual based 
on the relative position and duties of the holder of the position within a system) and formal 
authority. Therefore, it is assumed here that the forms of power institutional entrepreneurs 
exercise stretch from collective and integrative action (enabling, power to) to instrumental 
abilities that provide actors with influence at the expense of the others (power over) (Allen, 
2003: pp. 51-52).
It is believed here that to mobilise actors from different walks of life with different resources 
of power and to pool their differing knowledge institutional entrepreneurship relay requires, 
alongside power, an integration of various forms of knowledge. The effective promotion of 
regenerative medicine, as will be argued below in more detail, requires in depth understanding 
and knowledge of the substance of stem cell research and regenerative medicine as well as 
tightly interlinked sciences supporting their development (substance knowledge). The process 
also requires a good view on how general policy processes and specific policy processes of 
that field come together (policy knowledge), what policies might serve the development 
process under scrutiny best, what their dynamics are, who the key people are and how issues 
can be pulled through the multiple chain of decision-making to secure funding and robust 
enough institutional positioning among all other possible recipients of funding and policy 
attention. In addition, there should be actors who know how people think in this field, what 
the driving forces of firms, researchers, and other key players in the field are, and what the 
right measures in building networks are in this specific field and how they can be linked to 
wider development efforts to gain more power (process knowledge).
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!
!figure 1. power and knowledge in institutional entrepreneurship relays
the case, methodology and data 
Stem cell research and regenerative medicine in a nutshell
The specific field of activity this paper focuses on is known as regenerative medicine and tissue 
engineering. The terms regenerative medicine and tissue engineering have different roots, but 
today they are used interchangeably. The term ‘regenerative medicine’ was created in 2000 
and is now widely used to describe biomedical approaches to heal the body by stimulation on 
endogenous cells to repair damaged tissues, or transplantation of cells or engineered tissues to 
replace diseased or injured ones (Riazi, Kwon & Stanford, 2009). Thus, regenerative medicine 
refers to a group of biomedical approaches to clinical therapies that may involve the use of 
stem cells (Riazi, Kwon & Stanford, 2009; see also Lysagth, Jaklenec & Deweerd, 2007: 
p. 307; Mason & Dunnill, 2008b). 
The roots of tissue engineering can be traced back to 1933, but the modern era did not begin 
before the outset of the 1980s as a result of the research community’s increased knowledge 
and understanding of stem cell biology. Tissue engineering has been broadly defined as ‘the 
design and construction in the laboratory of living, functional components that can be used 
for the maintenance, regeneration or replacement of malfunctioning tissues’ (Polak & Bishop, 
2006). Tissue engineering utilises cells as building blocks for regenerated tissues; the basic 
components of it are cells, scaffolds and signals. 
Stem cells are cells, which are found in all multicellular organisms. The first observations 
of stem cells can be traced back to the mid-18th century, but research on stem cells has been 
developed over the last 6 decades, the most dynamically since the 1980s and 1990s (History 
of Stem Cell Research, 2010). Stem cells are able to regenerate tissues and organs and act as 
building blocks for all tissues in the body. Thus the potential of stem cells in clinical treatments 
is based on their multi-potent ability. Stem cells can be harvested from multiple sources, such as 
embryos, bone marrow and the stem cell populations of different organs and tissues (Nordforsk 
2007; Regea 2010; NIH, 2010). The use of stem cells in cell-based therapies requires removing 
the cells from their natural habitat, growing them to a large number in a culture dish, and either 
directly grafting them into a specific tissue environment, or using them for the generation of 
cells or tissues intended for transplantation (Nordforsk, 2007).
Stem cell research can be divided into the research of embryonic stem cells, adult stem cells 
and induced pluripotent stem cells (iPS) (NIH, 2010). 
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Embryonic stem cells are derived from embryos. Embryos are usually received as donations 
from couples that have undergone in-vitro fertilisation treatments. They are not derived from 
eggs fertilised in a woman’s body. These stem cells are the most promising cells for clinical 
application due to their great multi-potency. Neuron, muscle, fat, heart muscle and hepatocyte 
cells, among others, have been diversified from embryonic stem cells (Regea, 2010).
Adult stem cells can be isolated from the patient’s own tissue. Cells have been identified in 
many organs and tissues such as adipose tissue or bone marrow. Cells can be cultivated in cell 
cultures and then transferred back into the patient (Regea, 2010; NIH, 2010). Adult stem 
cells are less multi-potent than embryonic stem cells. Bone, cartilage, fat, tendon and muscle 
cells, among others, can be diversified from adult stem cells. The diversified cells can be used 
e.g. in the treatment of musculoskeletal injuries. (Regea, 2010; NIH, 2010). 
iPS, introduced by Japanese researchers in 2006, are adult cells that have been genetically 
reprogrammed to an embryonic stem cell-like state by being forced to express genes and 
factors important for maintaining the defining properties of embryonic stem cells. Generating 
pluripotent stem cells from normal adult cells opens up novel possibilities in regenerative 
medicine. Cells and tissues used in clinical transplantations could be derived from iPS cells 
generated from the patient’s own cells thus avoiding immunological problems. In the near 
future, iPS cells are believed to offer new efficient tools for drug development and even for 
patient-specific drug development. However, there is still a lot of work to be done. The iPS 
cell methods are based on the use of different viruses and the risk of cancer for patients today 
is still remarkable (NIH, 2010; Bongso & Richards, 2004).
Stem cell research has grown rapidly in the 2000s and the scientific achievements have 
created hopes for new treatments of severe incurable diseases in the field of regenerative 
medicine and tissue engineering. The promise of regenerative medicine is very exciting indeed 
but simultaneously the cost of product development, and most notably clinical trials, for the 
high-end applications is very high. Scientists are required to convince governments, insurance 
companies and major pharmaceutical or device companies to open their ‘deep pockets’ for 
future developments (Mason and Dunnill, 2008a: p. 351.) At all events, regenerative medicine 
has created new hope for such incurable diseases as, for example, diabetes, Parkinson’s disease, 
cancer and heart diseases. It is predicted that many of the diseases that are currently incurable 
or which require regular drug treatment will be beaten with therapies based on stem cell 
research and tissue engineering. 
Stem cell research differs from other types of research, it faces constant complex ethical and 
legislative questions, which have a huge impact on the research. From an ethical point of view 
the most complex debate concerns embryonic stem cell research and the moral status of the 
human embryo (Nordforsk, 2007.) Some cultures and religious groups see that embryos have 
intrinsic value and they regard very early human embryos as individualised human entities. 
They consider that the life of a person starts at the fertilisation of the ovum. Thus, using an 
embryo to derive stem cells (thereby destroying the embryo) is tantamount to killing a baby 
(Wertz, 2002). Other doctrines hold different views of the embryo’s moral status. At the other 
end there is a view of life, that a foetus outside the mother’s body does not have the same value 
as a foetus within her body, thus it is ethically acceptable to use, for example, surplus embryos 
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from in-vitro fertilisation treatments in order to derive stem cell lines (Nordforsk, 2007).
Stem cell research is also a very specific subject matter to legislate. Only few countries have 
adopted legislation devoted to stem cell research per se. Much of the stem cell research, namely 
research on stem cells taken from born humans, is covered by statutes concerning clinical 
medical research in general. The legislation on human embryonic and stem cell research varies 
widely in Europe, from a total ban on all embryo research to permissive regimes allowing even 
the creation of embryos solely for research purposes (Nordforsk, 2007). The most permissive 
positions are held in Belgium, Spain, Sweden and the United Kingdom. The EGE (European 
Group of Ethics) categorises the European Union (EU) Member States into four distinct 
groups according to how they regulate research on human embryonic stem cells:
1. Permissive position (embryo creation is allowed for research purposes): Belgium, Spain, 
Sweden and the United Kingdom.
2. Permissive position with restrictions (human embryonic stem cell derivation is allowed from 
embryos created as a result of assisted reproduction technology and in vitro fertilisation): 
e.g. Czech Republic, Denmark, Finland, France, Greece, Iceland, the Netherlands, 
Norway and Portugal.
3. Restrictive position (derivation of new human embryonic stem cell lines is restricted, but 
importation (under certain conditions) is allowed: Germany and Italy 
4. No specific legislation e.g. Bulgaria, Cyprus, Estonia, Ireland, Luxembourg, Latvia, and 
Romania. However, some countries have indicated in the EU process that they are 
against human embryonic stem cell research although they do not currently have specific 
legislation covering it (e.g. Austria, Lithuania, Malta, Poland and Slovakia). 
 (Nordforsk, 2007)
In Finland, the legislation is permissive with some restrictions. Dating back to 1999 
(9.4.1999/488) the Medical Research Act (Research Act) regulates Finnish stem cell research. 
It applies to research on born human beings, human foetuses and embryos. The law permits 
the research on surplus embryos for up to 14 days from the fertilisation and storage of embryos 
for up to 15 years. The creation of embryos for research by way of fertilisation is prohibited. 
The research to enable reproductive cloning is also prohibited. In addition to the Medical 
Research Act, the Act of the Medical Use of Human Organs, Tissues and Cells (Tissue Act) 
(2.2.2001/101) also stipulates the use of human embryos. The main difference between these 
two acts is that the Medical Research Act covers research on living foetuses inside a uterus, 
whereas the Tissue Act applies to research on dead human foetuses and stem cells derived from 
them (Finnish National Ethics Committees 2005.) 
The ethical issues and legislation have a huge impact on stem cell research. In Finland, 
the ethical atmosphere has been permissive – due partly to the Protestant, Lutheran religion 
(Nordforsk, 2007). The legislation has also been permissive, but the problem is that all the 
boundaries for the research are not fully covered by the legislation at the moment. From a 
global perspective ethical and legislative questions are relevant. For example, in the USA 
president George W. Bush forbade the creation of stem cell lines with public finance. Bush 
forbade public finance for the research of embryonic stem cells concerning the lines created 
after 2001. He also forbade public finance for cloning research. Radically reduced finance 
had a huge impact for the researchers as well as the geographical focus of the global research 
networks (Nordforsk, 2007; Finnish National Ethics Committees, 2005).   
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Regenerative medicine in Tampere
The case specific research question addressed in this article is: How did world class regenerative 
medicine come about in Tampere, Finland? The Regea Institute for Regenerative Medicine 
is the core of this narrative case and the regenerative medicine concentration in Tampere as 
well as being one of the cornerstones of the local biomaterial concentration. Established in 
2005 Regea is a joint institute under the administration of the University of Tampere. Regea 
was founded by the University of Tampere, Tampere University of Technology, Pirkanmaa 
Hospital District, Pirkanmaa University of Applied Sciences and Coxa, the Hospital for Joint 
Replacement. Regea’s activities are based on three foundation pillars: research, tissue bank 
operations and other services (e.g. renting clean room facilities, consulting, etc.). The focal 
research areas are stem cell research and research combining stem cells and biomaterials. 
The main goal is to focus on such R&D that enables the design of new forms of treatments 
based on tissue engineering. Although Regea is an academic institute under the auspices of 
a university, its focus is distinctly on clinical applications, not primarily on basic research. 
Therefore, Regea’s motto ‘from research to clinical care’ describes its strategy well. Regea started 
to conduct stem cell research in the beginning of 2005, and succeeded in implementing the 
first clinical treatment in 2007 (Regea, 2010).
In 2009 Regea’s budget was €3.7 million. The basic funding from the University of 
Tampere covered about one-fifth of the total budget. The rest of the budget has mostly been 
generated through project funding from such funding bodies as the Finnish Funding Agency 
for Technology and Innovation (Tekes), the Academy of Finland (research councils) and the 
Employment and Economic Development Centre11. Additionally, grants from other funding 
bodies, foundations and associations have formed an important part in the funding of Regea. 
It has also received some private donations every year. Only three of the total personnel of 
round 50–60 (including doctoral students) have permanent positions while the others are 
employed by fixed-term contracts because of the non-permanent nature of the funding. On 
top of that there are 20 students preparing their advanced special studies of final theses or 
working as trainees (Regea, 2009). 
Stem cell research and tissue engineering utilise several technology areas such as 
biotechnology, biomaterials and biomedical technology. The research, tissue bank operations 
and the clinical work in Regea are thus conducted in close collaboration with clinicians, cell 
biologists, technical experts, animal model experts and so on (Regea, 2010). Thus, Regea has 
numerous partners both in and outside Tampere. One of the strategic partners is the Tampere 
University of Technology. Its department of Biomedical Engineering represents the highest 
expertise in biomaterials and tissue engineering as well as biomeasuring in Finland. Thus, the 
research groups working at Tampere University of Technology supplement Regea’s know-how 
in cell growing and tissue engineering.
1 From the beginning of the year 2010 Centres for Economic Development, Transport and the Environment.
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Data and methodology
The study comprised four main phases. The first phase was a literature review of the theoretical 
framework focusing especially on institutional entrepreneurship in the context of regional 
innovation systems and science-based innovation (see also Sotarauta & Pulkkinen, 2011). 
The second phase consisted of the literature review of the history of Regea as well as stem 
cell research based on written material from the Internet, relevant journals, dozens of related 
newspaper articles, annual reports of Regea, respective policy documents as well as minutes 
of Regea’s founding planning group. Drawing on the secondary data the history of Regea 
and related activities were constructed chronologically. The main aim of this exercise was to 
describe the case and its evolution from the early days to the present day at a general level with 
the focus being on a sequence of events and critical incidents. The main aim of this phase was 
to identify a generic development pattern for further data gathering and analysis. 
In the third phase, 28 people were interviewed. The average duration of the interviews was 
70 minutes the longest interview lasting 90 minutes and the shortest 30 minutes. Six of the 
interviewees were employees of Regea (the director, the team leaders and the quality manager), 
and the rest of the interviewees were from local and regional development agencies, Tampere 
University Hospital, Universities, the Finnish Funding Agency for Technology and Innovation 
and Finnish Medicines Agency. All the interviews were recorded and transcribed into written 
format. The interviews followed the idea of the narrative interview (see Czarniawska, 2006) 
that was augmented with thematic clarifications. The themes were: 
1. Temporal change: what happened and why while the interviewee participated in the 
process, what were the critical incidents and significant events, why were they significant? 
What actually happened and when, and who did what in these events? When did these 
events occur? 
2. Institutions: what kind of institutions enabled and/or hampered the regenerative medicine 
development in Tampere, how were institutional obstacles crossed? 
3. The roles of the actors: Who influenced the course of events, how and why? 
In all the above-mentioned themes the main aim was to construct a narrative of the sequence 
of events to identify the actions of key people in their efforts to influence the course of events 
for regenerative medicine and thus to find out what drives the emergence of a science-based 
innovation concentration and how these kind of change processes are intentionally directed 
to serve several fields of interest. Finally, at the fourth phase, the analysis was carried out 
from three perspectives, already raised above, in mind (the process, network and governance 
perspectives) the main aim being to find the place and nature of institutional entrepreneurship 
in innovation systems.
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the unfoldIng sequence of events and InstItutIonal 
entrepreneurs carryIng the relay
How to grow an upper jaw within a stomach muscle? Successful treatments as a point 
of departure for the process analysis
The point of departure here is the fact that in 2008, for the first time in the world, a patient’s 
upper jaw was replaced with a bone transplant cultivated from the stem cells isolated from 
the patient’s own fatty tissue. The patient had lost roughly half of his upper jaw because of 
cancer. After the treatment the patient has been able to live a normal life with a normal upper 
jaw. Regea, with its collaborators, created the technology and Helsinki University Hospital 
carried out the surgery. In the process, the scientists were able to produce new bone cells by 
combining stem cells and biomaterials and then growing them into a jawbone of the correct 
shape and size (with the aid of a titanium frame) inside the patient’s stomach muscle. In six 
months the contents ossified and were filled with blood vessels and thus the designed bone 
and the surrounding muscle were removed together with their blood vessels and fitted in place 
(Bionext, 2010; Suomen Kuvalehti, 2008). This operation was a continuation of the successful 
clinical treatments of 2007, in which two deficiency patients were treated, jointly with the 
Tampere University Hospital, with a combination of fat stem cells and biomaterials. These 
treatments were also based on the adult stem cell technology developed at Regea. By the end 
of 2010, based on the technologies developed by Regea and its collaborators, approximately 
30 patients with serious bone deficiencies had been treated in Finnish hospitals (Bionext, 
2010). As a comparison, by early 2010, analogous treatments (external to the Regea network) 
have been received by only one patient in Germany (Tekes, 2010). The special feature in 
Regea’s technology is that no material derived from animals is used in the stem cell cultivation 
processes, which makes stem cells suitable for direct transplants to humans. 
The emergence of regenerative medicine in Tampere can be divided into four main 
phases: 
seeds of change; a) 
constructed collective interpretation; b) 
launch of activity; and c) 
hanging institutionalisation. d) 
In practice, the four phases in combination is about a long institutional change process and 
institutional entrepreneurship relay. 
Seeds of change
The strength and the competitive advantage of Regea’s research is that it combines stem cells 
and biomaterials. It continues the established and acknowledged science-based capacity in 
Tampere for research and innovation in biomaterial and tissue engineering that has engendered 
several spin-off firms in the field. The emergence of regenerative medicine in Tampere, and 
Regea at its core, was not a result of serendipity but of a conscious search for ways to strengthen 
the existing local biomaterial concentration and to find new possibilities in the intersections 
of biomaterials, tissue engineering and stem cell research. 
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The local roots of the biomaterial cluster and, hence also those of Regea, originate in 
Professor Pertti Törmälä’s and surgeon Pentti Rokkanen’s breakthrough in 1986 when, in 
a world first, they produced a bioabsorbable screw for repairing bone fractures. Törmälä 
and Rokkanen had been developing bioabsorbable bone screws and pins with their research 
groups since the mid 1970s. In the mid 1980s, Törmälä and his group established the first two 
enterprises to launch new products for the European and US markets. Since then the industry 
has evolved and today Tampere is acknowledged as one of the key centres of biomaterials in 
Finland (Restructuring and Development of Biosciences in Finland, 2007). In addition, the 
research on adult fat stem cells at the University of Tampere and the research on biomeasuring 
(biological and physiological measurement of human beings) conducted at the Tampere 
University of Technology and Technical Research Center of Finland (VTT) formed the basis 
for the local science capacity on stem cells and regenerative medicine. 
In the late 1990s, Professor Timo Ylikomi from the University of Tampere, and the above-
mentioned Professor Pertti Törmälä from Tampere University of Technology, took the lead 
in initiating a new development trajectory that eventually led to the above introduced facial 
bone replacements. Both of them believed that there is ‘something more’ in their research, 
and more widely in their field, something that, if applied correctly, might lead either to new 
business or other forms of societal benefits. Of course, at that time they were not fully capable 
of convincing other actors of what kind of solutions might emerge from their research if 
correctly cultivated. 
Drawing from their research groups and local expertise on biomaterials and adult fat stem 
cells they both introduced individually the idea of having an organisation for regenerative 
medicine in Tampere. The idea was fresh at that time; the first global findings in the field of 
stem cell technology were found only a few decades ago and the ‘human spare parts’ industry 
had just begun to emerge. Instead of their universities they both approached  local and regional 
development agencies with their ideas and launched a series of informal discussions about 
the possibilities of having an organisation for regenerative medicine in Tampere. They were 
prevented from fast action by two institutional obstacles:
 
the academic orientation of the University of Tampere rather than a proactive search for a) 
new innovations or business ventures slowed Professor Ylikomi down somewhat in the 
early days; and especially 
the scarcity of funds and know-how in supporting innovation and commercialisation.b) 
 
At all events, from the early beginning the core idea was to establish a firm to exploit emerging 
global opportunities and local expertise. The planning for the forthcoming business venture 
relied on the local and regional economic development community. 
Fortunately the enabling factors were stronger than the preventing factors. The major 
enabling factor to initiate the process was the conviction of the professors that science needs 
to be translated into practice. For these two professors science is not only something that is 
debated and developed within the scientific community but something that pushes some 
aspects of society forward. Related to that Törmälä’s experience that this actually can be done 
as well as him being a local role model in translating science into practice gave a strong push. 
Additionally, at that time academics and the local economic development policy community 
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already had a forthright locally embedded collaborative relationship that made it fairly easy 
for the professors to seek help outside academia. 
It should be noted that in retrospect it is possible to see what the outcomes of the science 
in question has been and, the successful treatments provide us with a convincing story that 
there was indeed something in the air. However, at that time, nobody was able exhaustively to 
explain what the possible outcomes might be and hence the first steps were hard to take. This is 
hardly a novel situation in the advent of a science-based innovation. By definition, innovation 
challenges prevailing mind-sets and practices and, innovation is usually born in ambiguity, 
uncertainty and a lack of clear vision (Lester & Piore 2004) and, as in this case, the inventors 
are able to discuss their work in professional language but what they often lack is the capacity 
to simplify the story and convince the resource-holders outside the scientific core about the 
future potential. It is also hard for policy-makers, funding bodies and possible beneficiaries to 
see the actual innovation through the hazy cloud of scientific reasoning flavoured by general 
noise generated by hype and hope, speculations and often fairly hollow innovation policy 
rhetoric that is more embedded in wishful thinking than factual evidence.  
In the seeds of change phase, the professors clearly took the lead in pushing their ideas 
forward and making them visible. They did not have the power required to take major steps 
forward by themselves nor knowledge on policies and processes about how to do it. They were 
able to push the relay forward to the second phase towards the local and regional development 
regime and hence towards the creation of collective interpretation because of their substance 
knowledge being deep, reputations as solid scientists being robust and by having adequate 
links to outside their immediate academic spheres.
Emergence of a collective interpretation
Even though the two professors opened a new development path, and in retrospect can be 
labelled institutional entrepreneurs, it is important to note that they did not work alone. The 
professors, as prominent as they were in their own fields, were not fully able to describe what the 
benefits, products and/or treatments based on the research might be. For these reasons, and from 
the outset, they started to use their network power to engage core actors, both from academia 
and policy community, in deliberations on how to proceed and what actually might be at stake 
in this field of research. The professors were able to tell convincing enough stories about their 
research and its potential to engage regional development agencies and other experts in collective 
deliberations about how to proceed and what might be gained by the commercialisation of this 
kind of research. Hence, they started attracting attention and, consequently, a local support 
community external to the academic spheres emerged to support their search for new solutions 
to exploit the opportunities ‘in the air’. At this phase, the support community appears as a 
crucial enabling factor for the institutional entrepreneurship relay to proceed without breaking. 
We define support community as a group of people having a feeling of fellowship with others, as 
a result of sharing common attitudes, interests, and objectives towards the willingness to provide 
the process with all possible assistance at their disposal. 
In this case, the support community consisted of the local and regional economic development 
actors as well as selected experts from the universities and the Tampere University Hospital. 
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The Centre of Expertise Programme for Health Care Technology proved to be especially 
beneficial for the continuation of the relay. First, working for the programme there were 
development officers whose job it was to boost university- society (incl. business) interaction 
in the fields relevant for this case, second, they followed closely the latest developments in 
the field and were quick to realise that there was indeed a lot of potential in the local human 
fat and biomaterial research. Consequently, in collaboration with other local and regional 
development agencies, they were able to take the lead in making the issue more understandable 
also for the wider policy audience, decision makers and resource holders.  
Simultaneously, with the intensifying local discussions, the tissue engineering industry 
(regenerative medicine) witnessed an ever-accelerating global growth (Lysaght & Reyes, 
2001). This, of course, boosted enthusiasm and belief in the local capacity and, fairly quickly 
the core group decided to aim for a global business instead of strengthening the local research 
capacity. An official planning group was assigned that was excited about the global prospects 
and composed a business plan for a new business venture by the funding of the Employment 
and Economic Development Centre (state development agency at a regional level). Everything 
looked promising; in early 2002 there was a strong belief that the new venture would obtain 
funding from venture capitalists. However, in the course of 2002 the situation began to change 
and already by the end of 2002 it became obvious that there was more global hype and hope 
than real business opportunities. Even though the number of firms active in the field globally 
did not decline dramatically, the financial community’s faith in tissue engineering began to 
diminish (Lysaght & Hazlehurst, 2004). Despite the public sector’s investments in R&D the 
industry had not yet succeeded in producing a single profitable and commercially successful 
product (Lysaght & Hazlehurst, 2004). The technology was not mature enough and true 
business opportunities were too far in the horizon. Consequently, the local planning group in 
Tampere realised that it is not possible to accomplish the business plan; there was no global 
business. At this stage the institutional entrepreneurship relay might have broken down. There 
was no business and hence no venture capital, the entire field appeared risky and enthusiasm 
started to wither away. But it did not wither away totally. The local potential was seen as too 
promising not to be developed further and therefore, the discussion moved to emphasise both 
the basic and applied research idea being that if there is no business opportunity then let the 
research capacity at the university be strengthened by launching a major research project.
In the collective interpretation phase the key actor was the assigned planning group with adequate 
substance knowledge about stem cell research and regenerative medicine complemented with 
the interpretive power to make the wider societal and economic potential visible as well as 
adequate policy knowledge to identify local, regional, national and international policies that 
could be used as funding sources. The support community consisted of local and regional 
development agencies as well as university and clinical actors (from the university hospital) 
and hence substance knowledge met understanding of the policy jungle. Additionally, the 
fact that the planning group was able to create a convincing interpretation of the science-
based business potential and to quickly adjust thus emerged collective interpretation in the 
light of new global developments proved important to keep the relay going and move from 
interpretation to action.
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The launch of activity
As indicated above, when the belief in business opportunities faded away the key actors started 
preparing more academic and clinical involvement. Instead of establishing a business venture 
the launch of activity included three main actions: 
the establishment of a tissue banka) 22; 
the eventual establishment of the Regea Institute for Regenerative Medicine; and b) 
the recruitment of highly skilled person(s) to lead Regea. c) 
The launch of activity and the continuation of the institutional entrepreneurship relay, saw 
not only new emphasis but also new actors taking the lead and, the ones having been on the 
front in the previous phases gradually moved to become backstage operators. 
After a series of negotiations between all the main parties in 2002, the Employment and 
Economic Development Centre committed to take part in the funding of Regea’s establishment 
and especially the funding of a GMP (Good Manufacturing Practices) level laboratory and 
clean room facilities. Another important funding body was the Pirkanmaa Hospital District 
(which owns and runs Tampere University Hospital). One of the reasons behind the decision 
of the Pirkanmaa Hospital District to become involved in Regea’s establishment was that 
at the same time the quality requirements for tissue bank operations changed dramatically. 
In Finland, the tissue bank operations had typically been taken care of by the hospitals by 
themselves. The staff had usually taken care of it in addition to their own duties. In the 
beginning of the 2000s the new National Tissue Act and European Union’s Tissues and Cell 
Directive (2004/23/EC) set strict quality requirements for tissue banks storing and handling 
human tissues. The new institutional regulations set a challenge for hospitals to modify their 
facilities to an adequate level. The Pirkanmaa Hospital District had two options: they were 
either to reorganise and upscale their own tissue bank internally or to outsource the operations 
to some other organisation with the required facilities. Regea, with new facilities to be built 
up, was a good option to cope with the changing situation. 
The collective interpretation created in phase two proved to be enticing enough. Now 
there was a broader interpretation of the prospects and requirements of regenerative medicine, 
a concrete project to work with and making a tissue bank was a crucial step for future 
development. At this point, it was significantly easier for the resource holders and decision 
makers to see what might lie ahead. Also the leadership of the University of Tampere came 
along and consequently Regea was established as a research project in 2004 under the Institute 
of Medical Technology at the University of Tampere. Later, in 2005, it became an independent 
joint institute under the administration of the University of Tampere but being founded and 
run in collaboration between the University of Tampere, Tampere University of Technology, 
Pirkanmaa Hospital District, Tampere University of Applied Sciences and the Coxa Hospital 
for Joint Replacement. Oral and maxillofacial surgeon Riitta Suuronen was invited to become 
the director of Regea. She was the first person to be recruited and from that humble start 
Regea has grown in a few years to be a prominent research centre with 60 employees. Professor 
2 Tissue bank is an organisation dealing with the operations pertaining to the handling, preservation, storage, 
and/or distribution of human-based tissues or cells. The tissue organisation may also be responsible for the 
acquisition and research of the tissues and cells. (Source: Regea)
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Suuronen herself has said that in the beginning there was basically nothing; she was asked to 
join the University of Tampere and Regea by a promise that ‘there is no money, no faculty, no 
premises but some prospects and ambitious goals’.
At that stage, it seemed like there were only enabling factors such as a strong knowledge 
base and research capacity in the field, endowed professorship to the University of Tampere 
by the city of Tampere and successful recruitments. The most visible of the recruitments, 
due to professorship endowed by the City of Tampere, occurred when Regea succeeded in 
recruiting a world-leading Finnish scholar, Professor Outi Hovatta, from Karolinska Institutet 
in Sweden to Regea. Professor Hovatta is one of the leading stem cell researchers in the world. 
She has a long internationally recognised career in the fields of fertility treatments and stem 
cell research. Professor Hovatta’s credit in Regea’s early days was twofold: 
 Regea’s stem cell research began quickly because of her know-how and she also brought a) 
along the first seven embryonic lines from Karolinska Institutet to Regea, which was one 
of the reasons behind the expeditious start of stem cell research in Tampere. 
 By appointing professor Hovatta Regea, who also became more or less instantly a credible b) 
player in the academic and funding spheres, Regea also gained a lot of media visibility in 
Finland. 
A few years later, in 2008 Hovatta resigned from Regea and continued her research work at 
the Karolinska Institutet and at the University of Kuopio in Finland. Of course, as stated 
above, the changing legislation and consequent establishment of the tissue bank operations 
also had a remarkable role in enabling the surface of Regea. In addition, the atmosphere for 
new innovative ideas in the field of biotechnology was favourable in Tampere. In 2003, the 
City of Tampere launched the BioneXt Tampere programme aimed at further developing the 
city’s biotechnology sector3. The programme also aimed to set up new openings in the field 
of biotechnology. Regea fulfilled this objective perfectly; it was a long sought after new piece 
in a larger constantly emerging puzzle.  
In the launch of the activity phase the lead of the relay moved from the support community 
back to the university and, after her recruitment especially, to Regea’s director. Simultaneously, 
the support community started to change gradually. If it earlier consisted of local and regional 
development agencies possessing policy and process knowledge, now the research and clinical 
community with the substance knowledge took a more prominent role. This also meant that 
the policy and process knowledge started to diminish and substance knowledge began to be the 
main driver again. Prior to the establishment of Regea, policy and process knowledge in concert 
with institutional and network power were needed to carry the relay forward but after the launch 
of tissue bank and research projects the process stabilised to fairly standard research operations 
for a while, but not for long. Already at this phase, it was obvious that regenerative medicine 
was not fully institutionalised in Tampere. In practice Regea was a collection of projects and 
only the core management personnel (director, quality manager, a secretary) had a permanent 
contract with the university and everybody else was employed on a temporary basis. 
3 BioneXt Tampere is an investment and development programme that focuses on biotechnological education, 
top-level research, product development, clinical application and possibilities in international commercialisa-
tion. The programme unites the strong technological expertise in the Tampere region with new biological and 
medical research (Bionext, 2010).
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In Finland, as critics argue, innovation is preferred to basic research funding and the entire 
system is based on funding fixed-term (relatively short) projects instead of long-term research 
or structures and the lack of financial capacity to invest in new openings at the universities 
(for the evaluation of the Finnish national innovation system see Veugelars et al, 2009). 
The regenerative medicine case under scrutiny here seems to verify these observations. The 
characteristics typical of the Finnish innovation and science policies make the system fairly 
dynamic and enable integration of various policies and funding sources to support bottom-
up initiatives but simultaneously it makes the institutionalisation of new and promising 
developments difficult.
The regenerative medicine case indicates that during the critical incidents the role of local 
and regional development agencies becomes more pronounced. The academic community is 
not capable of navigating in the midst of several policies and power regimes. For example, 
in the case under investigation here, the question is not only about innovation policy but 
also about science policy, healthcare policy, local and regional economic development policy 
as well as individual decisions of such big players as universities and the university hospital. 
Local and regional development agencies may not have abundant financial resources or much 
understanding on the substance in question but at their best they are the ones who can 
influence across the sectors and enable a collective dominant interpretation to emerge (see 
also Sotarauta 2009 and 2010).  
In a way, the third phase ended with excitement and prospects that characterised the 
early phases too. The institute was established; the first treatments were great successes that 
guaranteed not only scientific and clinical credentials but also global media attention. The 
future appeared as nothing but glorious. In practice, the relay was far from the goal line. 
Regenerative medicine in Tampere was still more a collection of research projects than an 
established research and innovation concentration. The collective interpretation had been 
translated into activity but new challenges lay ahead: how to institutionalise regenerative 
medicine in Tampere? Who would carry the relay forward?
The hanging institutionalisation 
Breakthrough operations opened up new ways to treat severe tissue damage and made the 
prospects of custom-made living spare parts for humans a step closer to reality. Obviously, success 
in implementing the first pioneering operations has paved Regea’s way towards standardised 
clinical treatments and the ‘business’ of human spare parts. However, in the advent of the fourth 
phase, there is clearly a lack of knowledge and power to make Tampere’s regenerative medicine a 
permanent element in the Finnish science and innovation system. One might argue that it is still 
hanging in the air and even though the future prospects are obvious and promising there are also 
several strategic issues. One of the main issues is the commercialisation of the created technology 
with limited financial resources available in the country. There have been several attempts to 
find a way to do this but so far the board of Regea and related actors have not been able to find 
a way to accomplish it viably and from Finland without selling the patents abroad. 
Second, among the strategically important issues is also whether, how and when Tampere 
University Hospital, or some another hospital, would change its routines to integrate regenerative 
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medicine into its standard repertoire. At this point in time, according to our interviewees, the 
treatments are hugely expensive but without them becoming a standard part of the hospital 
operations the cost will not decrease. There have been some initial discussions to establish 
a ‘Tampere Hospital for Advanced Therapies’ that would serve not only Finnish taxpayers 
but also as a hub for healthcare tourism especially in the field of facial bone replacements. 
However, at the time of writing, there is no indication as to whether this initiative will move 
forward or not. Additionally, if the number of treatments were to grow, Regea would need to 
go through a series of expensive clinical trials necessitated by the pharmaceutical legislation. 
So far the institutional obstacles have kept the number of treatments at a low level. The third 
strategic issue is that while Regea’s reputation is growing rapidly so is the key persons’ global 
visibility and reputation. Consequently, one of the main issues is that the key persons may 
leave Tampere to go abroad to gain a more established position without the constant need to 
hunt for external funding. 
Fourth, regenerative medicine is a field of science that requires patient and long-term 
funding to revolutionise medical care and, therefore the main issues also include the scarcity 
of long-term research funding in the system as a whole and within the universities (University 
of Tampere and Tampere University of Technology) involved in the process. In 2010, the 
universities were negotiating and planning for a joint Faculty (Faculty of Medical Technology 
[working name]) that would integrate the main departments and research groups from two 
universities into one entity. This, of course, can only serve as a partial solution but is a step 
forward nonetheless. 
The institutional entrepreneurship relay will not move forward to the institutionalisation 
of regenerative medicine in Tampere without reborn support from the outside research 
and clinical community. What is now needed is ‘big institutional and resource power’ to 
channel adequate resources to something that has proven its innovative capacity and global 
reach. Here, also a new kind of interpretive power is needed. In the course of institutional 
entrepreneurship relay the key actors with their support community were first able to construct 
a credible enough interpretation of the local scientific potential in the field of biomaterials to 
get things moving and, secondly they were able to integrate several organisations and funding 
sources to support the launch of activity. This required an interpretation that linked science 
with local and regional economic development as well as developments in healthcare. Now, 
the challenge is to move forward again and to create such an interpretation on the role of 
regenerative medicine that would open new horizons for the Finnish hospitals, most notably 
for Tampere University Hospital. Additionally, all this may not be able to be implemented 
without considerable commitment into basic funding by the national level players.
In the advent of the fourth phase, there is clearly a lack of knowledge about the wider 
policy processes needed to keep the relay moving and the institutional and interpretive power 
to push it forward. The first breakthrough treatments, an emerging global reputation, the 
expertise of the local knowledge community and the active work of the main institutional 
entrepreneurs function as enabling factors for the future but it seems obvious that fresh 
institutional entrepreneurs are needed to enable the relay to move on towards new and still 
unknown phases.
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conclusIons
The study reported in this paper shows, first of all, that institutional entrepreneurs do exist. 
The case of regenerative medicine in Tampere clearly shows that there are indeed individual 
actors who initiate divergent changes and work to implement them. This is connected to 
the second general observation that institutional entrepreneurs are required to influence not 
only within the boundaries of the organisations and communities that authorise them or 
within their ‘own policy domains’, but they consciously need to reach beyond their familiar 
fields of activity and policy spheres to reach such spheres and spaces in which their actions 
and words need to have influence despite having no authorisation. The institutional change 
process involves a series of interrelated decisions and actions crossing many boundaries that are 
continuously shaped both by contemporary challenges, future prospects and earlier decisions. 
Institutionalisation of a new science-based innovation concentration is a long process that is 
based on an existing and constantly evolving expertise as well as reinterpretations of it all. 
Consequently, third, the main conclusion of the study reported here is that institutional 
entrepreneurship is not a solo activity but a relay of power and knowledge in time. Institutional 
entrepreneurship involves an array of actors with various backgrounds, resources and sources 
of power and thus institutional entrepreneurship might offer us a way to study institutional 
change processes as multi-scalar and multi-actor processes in time as well as innovation 
systems from a fresh perspective; to achieve results a development process needs to be, one 
way or another, shared in time. No one can master all the pressures and all of these spheres 
of knowledge and power alone. 
The fourth observation is that for an institutional entrepreneurship relay to proceed 
successfully a support community is required that is not always at the core of the relay but that 
removes institutional obstacles and enables the process in many ways depending on the phase 
it is on. The scientific knowledge base was the core in the first phase but the future prospects 
stemming from it needed to be reinterpreted for a wider decision and policy-maker audience. 
This was done in the collective interpretation phase with the help of the support community 
external to the science and clinical community. At this phase, the support community 
pushed the relay forward by seeking differences and similarities in actors’ interpretations and 
especially by being able to synthesise different interpretations and goals derived from them 
in collaboration with the scientific and clinical players. The support community’s role was to 
convene actors for dialogue, mediate information and hence also to construct new knowledge; 
it interpreted, for example, academic thinking and talk to policy language, and vice versa. It 
was able to exercise wider network power than the scientists, i.e. power to engage biomaterials 
with the local and regional economic development discussion and policies.
The fifth observation is that, in the course of relay, there is a need to integrate interpretive, 
network and institutional power in time and place. The integration of various forms of power 
provides the relay with necessary force that keeps it going. In the case under scrutiny here, the 
advent of regenerative medicine in Tampere, it is fairly easy to conclude that in spite of a fairly 
general conviction among the support community of the second phase regenerative medicine 
is not yet an established element of the local institutional configuration in Tampere. It does 
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have a prominent and recognised position but the success has hidden the fact that it is still 
a collection of projects instead of a long-term investment in a revolutionary medicine. The 
growth of Regea outpaced the rest of the system. The successful finalising of the institutional 
entrepreneurship relay would require new institutional entrepreneurs to emerge; the ones 
having had key positions at the previous phases do not possess the power and/or knowledge 
needed to carry the relay further. What is needed is a high-level institutional power that for 
its part requires wider network power. It may well be that these forms of power cannot be 
unleashed without appealing and convicting enough interpretation about how regenerative 
medicine will change medical care and healthcare policy nationally. Perhaps a business venture 
is not the way forward at this phase either but reaching hospitals and changing their routines 
is. As is well known, this is a daunting task indeed.  
Sixth, the study reported here shows how crucial but difficult it is to keep a relay in motion 
without letting it break down in the critical phases of the process. In the case of regenerative 
medicine in Tampere, the institutional entrepreneurship relay was not a conscious and pre-
designed relay but rather a phase-by-phase evolving search for next steps, vision, required forms 
of knowledge and power. Therefore, seventh, in dynamic innovation systems institutional 
entrepreneurs need strong leadership capacity. Here we are in line with Yukl (2002: p. 2) who 
sees leadership as involving a process whereby ‘intentional influence is exerted by one person 
over other people to guide, structure, and facilitate activities and relationships in a group or 
organization’. This study also shows that instead of focusing on ‘heroic leadership’, or other 
forms of leader-centric analyses, a process, network and governance oriented study with a 
strong temporal flavour not only adds new insights on institutional entrepreneurship and 
leadership but also on institutions framing and shaping innovation systems.
This study also reveals, eighth, that when approaching innovation systems and related 
institutionalisation processes through an institutional entrepreneurship lens, the differentiation 
between national, sectoral, and regional innovation systems appear not as clear-cut as the 
literature seems to imply. The case under scrutiny is clearly about strengthening the local 
innovation capacity in biomaterials and especially in regenerative medicine. Simultaneously, it 
is clearly part of the sectoral innovation system in respective fields and the main funding bodies 
(Academy of Finland; Tekes; and the Regional State Office; the Employment and Economic 
Development Centre) being among the core elements in the national innovation system (see 
Veugelars et al, 2009) one might also argue that the question is about the strengthening of one 
specific local element in a wider national system. Furthermore, to make the situation more 
complicated, from a local economic development point of view this case is one of the strategic 
priorities in the efforts to boost local economic development. Of course, various ‘innovation 
systems’ are analytical and policy-focusing devices that are useful in efforts to understand and 
explain some specific feature of innovation and they need to be complemented with specific 
analytical lenses that provide additional analytical leverage. 
In their efforts to change institutions, institutional entrepreneurs of the case reported here 
operate in the middle of open-ended and fuzzy situations where they are constantly required 
to cross the innovation, science, local and regional economic development and healthcare 
policy boundaries; they influence beyond their own territories and policy spheres. For these 
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reasons, institutional entrepreneurship is a relay in time instead of straightforward actions 
here and now. An institutional entrepreneurship relay for science-based innovation differs 
from, say, a relay race significantly. In a relay race, there is a fixed team and everybody knows 
their place in the team and one runner is replaced by another runner. Even more importantly, 
they know that they are members of a team and that they are participating in a race. In an 
institutional entrepreneurship relay for science-based innovation, it is much harder to know 
what is the team, coalition or network one is a member of, as hard as it may be to know what 
the race is about or to detect its beginning and finish. The kind of relay discussed here usually 
has many ‘runners’ on a track simultaneously, there is no clear order of runners, there are 
many managers, team leaders, anchor runners and other specialists ‘who know best’. The trick 
is to keep the relay in motion and continuously search for both desired futures and needed 
ingredients for the next phases.
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